Ling-Ying Wu (Lingying Wu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Peritoneal Dialysis

Prognostic Factors

Top Venues

Journal of gynecologic oncology

Journal of oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer cell international

This page only lists publications with an associated author ORCID identifier.

Publications

Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Ling-Ying Wu, Hongwen Yao
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology (2024)
Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Ling-Ying Wu, Hongwen Yao
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 35 (4) (2024)
Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Ling-Ying Wu, Hongwen Yao
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 35 (4) (2024)
He-Rui Yao, Min Yan, Zhongsheng Tong, Xinhong Wu, Min-Hee Ryu, John J Park, Jee Hyun Kim, Yahua Zhong, Yiming Zhao, Mark Voskoboynik, Yongmei Yin, Kan Liu, Andreas Kaubisch, Caigang Liu, Jian Zhang, Shouman Wang, Seock-Ah Im, Vinod Ganju, Minal Barve, Hui Li, Changsheng Ye, Amitesh C Roy, Li-Yuan Bai, Chia-Jui Yen, Shanzhi Gu, Yung-Chang Lin, Ling-Ying Wu, Lequn Bao, Kaijing Zhao, Yu Shen, Shangyi Rong, Xiaoyu Zhu, Erwei Song
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Ling-Ying Wu, Hongwen Yao
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 35 (4) (2024)
Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Ling-Ying Wu, Hongwen Yao
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 35 (4) (2024)
Jing Zuo, Wei Duan, Mingxuan Zhao, Zhendong Chen, Jie Lin, Huaqiu Shi, Ou Jiang, Youzhong Zhang, Meiyu Fang, Li Wang, Wei Wang, Yong Huang, Junyan Yu, Xiaoxue Zhang, Weiqing Pu, Deshun Hao, Fenglin She, Xiugao Yang, Ying Chen, Qizhi Tang, Xiao Zhang, Miao Niu, Yan'e Song, Ling-Ying Wu
Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial. Cancer communications (London, England) (2024)
Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Ling-Ying Wu, Hongwen Yao
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 35 (4) (2024)
Leilei Liang, Yunshu Zhu, Jian Li, Jia Zeng, Ling-Ying Wu
ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Jusheng An, Jie Tang, Benjamin X Li, Huihua Xiong, Hui Qiu, Lin Luo, Li Wang, Danbo Wang, Qi Zhou, Qin Xu, Honglin Song, Yunyan Zhang, Hong-Ping Zhang, Yujie Li, Xiaohui Yu, Jing Zhang, Rachel Ng, Wayne Zhao, Michael Wong, Xiangrong Dai, Guiling Li, Ling-Ying Wu
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Ning Li, Qi Liu, Yu Tian, Ling-Ying Wu
Overview of fuzuloparib in the treatment of ovarian cancer: background and future perspective. Journal of gynecologic oncology 33 (6) (2022)
Shuang-Zheng Jia, Hong-Wen Yao, Ning Li, Jun-Jun Yang, Yang Xiang, Shan Zheng, Jin-Hua Leng, Ling-Ying Wu
Prognosis and Prognostic Factors of Serous Borderline Tumor-Micropapillary Variant: Retrospective Study of 200 Patients with Long-Term Follow-Up. Journal of oncology 2022 (2022)
Ning Li, Youzhong Zhang, Jing Wang, Jian Qing Zhu, Li Wang, Xiaohua Wu, Desheng Yao, Qiang Wu, Jihong Liu, Junying Tang, Rutie Yin, Ge Lou, Ruifang An, Guonan Zhang, Xiaoping Xia, Qingshui Li, Yaping Zhu, Hong Zheng, Xinfeng Yang, Yuanjing Hu, Xin Zhang, Min Hao, Yi Huang, Zhongqiu Lin, Dong Wang, Xiaoqing Guo, Shuzhong Yao, Xiaoyun Wan, Huaijun Zhou, Liangqing Yao, Xielan Yang, Heng Cui, Yuanguang Meng, Songling Zhang, Jing Qu, Ben Zhang, Jianjun Zou, Ling-Ying Wu
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Leilei Liang, Jian Li, Jing Yu, Jing Liu, Lin Xiu, Jia Zeng, Tiantian Wang, Ning Li, Ling-Ying Wu
Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer. Cancer cell international 22 (1) (2022)
Jing Yu, Ting-Ting Liu, Lei-Lei Liang, Jing Liu, Hong-Qing Cai, Jia Zeng, Tian-Tian Wang, Jian Li, Lin Xiu, Ning Li, Ling-Ying Wu
Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer. Cancer cell international 21 (1) (2021)
Ning Li, Ziyi Wang, Guangwen Yuan, Yangchun Sun, Rong Zhang, Xiaoguang Li, Nan Li, Jing Wang, Ling-Ying Wu
An Oral Small Molecule VEGFR2 Inhibitor, Apatinib, in Patients with Recurrent or Refractory Cervical Cancer: A Real World Study. Journal of oncology 2020 (2020)